InBios International, Inc.
InBios develops and manufactures diagnostic test kits for emerging infectious diseases and biothreats affecting global public health. Products are designed for superior performance and value and include 7 EUA Covid-19 assays, FDA cleared in vitro diagnostic assays for Zika, West Nile, Dengue, Chagas, Cutaneous and Visceral Leishmaniasis. Assays in the pipeline or available for export include diagnostics for Chikungunya, Scrub Typhus, Filaria, Strongyloidiasis, Melioidosis, and Anthrax.
Additional Info
We will be displaying a new product or promoting a new indication/enhanced feature for an existing product in our booth!
YesIncluded in the Export Interest Directory?
YesProducts to be exported:
ELISA, Rapid Test, and PCR kits. Monoclonal antibodies. COVID-19, Zika, Dengue, West Nile, Japanese Encephalitis, Chikungunya, Scrub Typhus, Chagas, Visceral Leishmaniasis, Cutaneous Leishmaniasis, Filaria.Business Needs:
Direct Sales, Distributor/Agent/Representative, Licensing Agreements, Service (Maintenance, Training, Logistics, etc.)